Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis

A population pharmacokinetic (PopPK) model of delamanid in patients with pulmonary multidrug-resistant tuberculosis (MDR-TB) was developed using data from four delamanid clinical trials. The final PopPK data set contained 20,483 plasma samples from 744 patients with MDR-TB receiving an optimized bac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaofeng, Mallikaarjun, Suresh, Gibiansky, Ekaterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927850/
https://www.ncbi.nlm.nih.gov/pubmed/33106258
http://dx.doi.org/10.1128/AAC.01202-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927850/
https://www.ncbi.nlm.nih.gov/pubmed/33106258
http://dx.doi.org/10.1128/AAC.01202-20

Ejemplares similares